Intrathecal administration, as usually results in death (see Precautions).
Patients with the demyelinating form of Charcot-Marie-Tooth Syndrome should not be given vincristine sulfate.
Careful attention should be given to those conditions listed under Precautions.
Vincristine is contraindicated in patients who are hypersensitive to vincristine, vinca alkaloids or any other ingredient in the preparation.
Vincristine should not be administered to patients while they are receiving radiation therapy through ports that include the liver.
Vincristine should not be administered to women while they are breast-feeding (see Use in Pregnancy & Lactation).